IL-10 production by B Cells expressing CD5 with the alternative exon 1B

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 280-285

  Garaud, Soizic ^a   Le Dantec, Christelle ^a   De Mendoza, Agnès Revol ^a   Mageed, Rizgar A ^a   Youinou, Pierre ^a,b,c   Renaudineau, Yves ^a,b  

^a Universite de Brest   (France)

^b CHU MORVAN   (France)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Autoimmunity; B cells; CD5; Interleukin 10; Isoform

Indexed keywords

CD5 ANTIGEN; COMPLEMENTARY DNA; INTERLEUKIN 10; SIGNAL PEPTIDE;

ANIMAL CELL; B LYMPHOCYTE; CELL SUBPOPULATION; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 69949132496     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04616.x     Document Type: Conference Paper

References (16)

1. Renaudineau, Y. et al. 2005. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes. Genes Immun. 6: 663-671. (Pubitemid 41741711)
2. Berland, R. & H.H. Wortis. 1998. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J. Immunol. 161: 277-285.
3. Arman, M. et al. 2004. Transcriptional regulation of human CD5: important role of Ets transcription factors in CD5 expression in T cells. J. Immunol. 172: 7519-7529.
4. Renaudineau Y. et al. 2005. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood 106: 2781-2789.
5. Garaud, S. et al. 2008. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J. Immunol. 181: 2010-2018.
6. Kasaian, M.T., H. Ikematsu & P. Casali. 1992. Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies. J. Immunol. 148: 2690-2702.
7. O'Garra, A. & M. Howard. 1992. IL-10 production by CD5 B cells. Ann. N. Y. Acad. Sci. 651: 182-199.
8. Gary-Gouy, H. et al. 2002. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 100: 4537-4543.
9. Burdin, N., F. Rousset & J. Banchereau. 1997. B-cell-derived IL-10: production and function. Methods 11: 98-111.
10. D́iaz-Alderete, A. et al. 2004. IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus. J. Autoimmun. 23: 379-383.
11. Paavonen, T. et al. 1990. CD5 mRNA expression and auto-antibody production in early human B cells immortalized by EBV. Scand. J. Immunol. 31: 269-274.
12. Gross, H.J. et al. 1996. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. Blood 87: 5113-5126.
13. Matsushita, T. et al. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
14. Jamin, C. et al. 2008. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum. 58: 1900-1906.
15. Youinou, P. & Y. Renaudineau. 2007. The paradox of CD5-expressing B cells in systemic lupus erythe-matosus. Autoimmun. Rev. 7: 149-154.
16. Youinou, P. 2007. B cell conducts the lymphocyte orchestra. J. Autoimmun. 28: 143-151.